We develop custom solutions based upon the specific corporate objectives of our clients. Our prescribed methodologies are rooted in the understanding gained from years of experience working with life sciences companies of all organizational types and sizes.
Engage with us and you have access to a team of highly educated (MBA, PhD level), seasoned professionals with industry (Sales and Marketing) and academic experience. All of our consultants have proficiency in the engagement and provision of consulting services to senior R&D, Sales and Marketing and C-level Executives within the pharmaceutical, biotechnology and medical device industries.
Commercial due diligence - Assessment and evaluation of a target company's product portfolio with respect to current and forecast market opportunity.
Routinely, an assignment will map the current and evolving competitive landscape and analyse a target company's revenue generation and position within the market, while also identifying any relevant threats and weaknesses which may impact forward strategy.
Technical due diligence - this may routinely involve assessment of expert clinician review of usability and fit of product(s) within clinical workflows, understanding of product uptake potential within a defined target end user physician group, IP portfolio analysis (including freedom-to-operate, FTO analysis) and current/pending regulatory submissions.
Due diligence experience includes:
Our overriding aim in market opportunity assessment is to fully explore and report on all of the dynamics shaping a particular market landscape. We can then be confident that we have provided our clients with the most rigorous, defensible information.
Understanding the scale of the market opportunity for a particular product or service does not depend solely upon identifying the size of the market in monetary terms. A comprehensive market analysis may require consideration of a range of topics, such as:
This list is not exhaustive; each assignment must be approached with an open mind if all appropriate factors are to be recognized and investigated.
No company can afford to develop and launch products that the market does not need. Veracity Health can help, both at the early stages of development--to ensure that the product will truly answer an authentic, and sometimes unmet, medical need--and closer to launch, when messaging must be created which will position the new product as desired in the end-user's mind.
The exploratory methods used in research related to new product development include in-depth interviews and small and large focus groups. These may, depending upon the project, be conducted in-person face-to-face, by telephone, in an on-line conference, or using a mix of methods. Analysis of the qualitative findings allows us to advise the client of the likelihood of success, paths to commercialisation and reimbursement as well as to point out potential hurdles which may come to light from the interviews.
In-depth market analyses identifying market developments, market forecasting and competitive dynamics within the biotech, pharmaceutical and medical device sectors.
A number of themes reflecting the advances being made in some key areas have been identified and we aim to publish 1-2 reports early 2025.
©Copyright. All rights reserved.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.